Dallas 2015 TFQO: Koen Monsieurs 372 EVREV 1: Koen Monsieurs 372 EVREV 2: Ahamed Idris 349 Taskforce: BLS BLS366 Chest Compression Depth (adults)

Slides:



Advertisements
Similar presentations
Third Annual EMS R ESEARCH S UMMIT Third Annual EMS R ESEARCH S UMMIT.
Advertisements

Dallas 2015 TFQO: Allan de Caen COI#38 EVREV 1: Melissa Parker COI#259 EVREV 1: Takanari Ikeyama COI#235 Taskforce: Pediatrics Peds 820 : The use of fluids.
Dallas 2015 TFQO: Myra Wyckoff #COI EVREV 1: Myra Wyckoff #COI EVREV 2: Lindsay Mildenhall #107 Taskforce: NRP NRP: 605 Two thumb verses two finger.
Science Driving the Future of Basic Life Support Paris Hotel and Casino  Las Vegas, Nevada Presented by: Dana Edelson, MD, MS, FAHA, FHM Medical Director.
Dallas 2015 TFQO: Marya Strand, MD, MS; COI#222 EVREV 1: Marya Strand, MD, MS; COI#222 EVREV 1: Takahiro Sugiura, MD; COI#224 Taskforce: NLS Umbilical.
Dallas : CPAP and IPPV In spontaneously breathing preterm infants with respiratory distress requiring respiratory support in the delivery room,
Chicago 2014 TFQO: Kee-Chong Ng (#COI = 113) EVREV 1: Gene Ong (#COI = 118) EVREV 2: Jos Bruinenberg (#COI = 19) Taskforce: Pediatric Taskforce The Long.
Dallas 2015 TFQO: S. Velaphi COI #242 EVREVs: N. Singhal COI#213 H. Ersdal COI#76 Taskforce: Neonatal Maintaining Infant Temperature During Delivery Room.
Many thanks to Dr. Kudenchuk for sharing his slides
Dallas 2015 TFQO: EVREVs: de Almeida, Maria Fernanda COI# Trevisanuto, Daniele COI# Taskforce: Neonatal Warming Adjunts #599 Among preterm neonates who.
Chicago 2014 Peter Morley, Eddy Lang E3, GRADE expert Incorporating lower levels of evidence.
Critically Evaluating the Evidence: Tools for Appraisal Elizabeth A. Crabtree, MPH, PhD (c) Director of Evidence-Based Practice, Quality Management Assistant.
Dallas 2015 TFQO: David Stanton COI 328 EVREVs: Volker Wenzel COI 253& Emmanuelle Bourdon COI 333 Taskforce: BLS Passive ventilation techniques.
Dallas 2015 TFQO: Karen Woolfrey COI #261 EVREV 1: Karen Woolfrey COI 261 EVREV 2: Daniel Pichel COI # 513 Taskforce: ACS ACS 335: Pre-hospital ADP- Receptor.
Dallas 2015 TFQO: Jerry Nolan #310 EVREV 1: Jerry Nolan COI #301 EVREV 2: Charles Deakin COI #221 Taskforce: ALS ALS 714 : Advanced airway placement (SGA.
Peds-818: Pediatric Early Warning Scores
Dallas 2015 TFQO: Vinay Nadkarni MD COI#249 EVREV 1: Graeme Maclaren MBBS COI#98 EVREV 2: Ravi Thiagarajan MBBS, MPH COI#149 Taskforce: PALS Peds 819 :
Dallas 2015 TFQO: Karen Woolfrey COI #261 EVREV 1: Karen Woolfrey COI #261 EVREV 2: Daniel Pichel COI #513 Taskforce: ACS ACS 873: Pre-hospital STEMI Activation.
Dallas 2015 TFQO: Jeffry Pearlman COI# 187 EVREV 1: Enrique Udaeta COI# 239 EVREV 1: Edgardo Ezslyd COI# 277 Taskforce: NRP Laryngeal Mask Airway (NRP.
INCLUSION/EXCLUSION CRITERIA 1. The following are considerations when defining the cardiac arrest trial patient population (i.e., the inclusion/exclusion.
Dallas 2015 TFQO: EVREVs: Aaron Donoghue / Jonathan Duff Taskforce: EIT Teaching Compression-Only CPR.
6th June 2004 By Norah A A Al Khathlan M.D. JOURNAL CLUB A Comparison of High-Dose and Standard-dose Epinephrine in Children with Cardiac Arrest NEJM 350;17April.
Dallas 2015 TFQO: Masanori Tamura #147 EVREV 1: Masanori Tamura #147 EVREV 2: Susan Niermeyer #252 Delayed Cord Clamping in Preterm Infants Including those.
NRP: 862: Use of Feedback CPR Devices for Neonatal Cardiac Arrest NRP: 863: Use of Feedback CPR Devices to detect ROSC for Neonatal Cardiac Arrest TFQO:
Chicago 2014 TFQO: Peter Meaney #COI 149 EVREV 1: Richard Aickin #COI 153 EVREV 1: Peter Meaney #COI 149 Taskforce: Pediatrics Resuscitation fluids (Peds)
Dallas 2015 TFQO: Marilyn Escobedo COI#78 EVREV 1: Marilyn Escobedo COI#78 EVREV 2: Henry Lee COI#135 Taskforce: NRP Babies born to mothers who are hypothermic.
Dallas 2015 TFQO: Robert Greif EVREVs: Jan Breckwoldt, Henrik Fischer Taskforce: Education Implementation and Training (EIT) AED training methods.
Dallas 2015 TFQO: Enrique Udaeta COI# 239 EVREV 1: Enrique Udaeta COI# 239 EVREV 1: Edgardo Ezslyd COI# 277 Taskforce: NRP Laryngeal Mask Airway (NRP 618)
Dallas 2015 TFQO: EVREVs: Guinsburg, Ruth COI# McGowan, Jane COI# Taskforce: Neonatal Apgar Zero #896 In infants ≥36 weeks GA with an Apgar score.
Dallas 2015 TFQO: Name EVREV 1: Jonathan Wyllie COI #282 EVREV 1: Jeff Perlman COI #262 Taskforce: Newborn Temperature Maintenance in the Delivery room.
Chicago 2014 TFQO: Nikolaos Nikolaou COI#253 EVREV 1: Nikolaos Nikolaou COI#253 EVREV 2: Farzin BeyguiCOI#202 Taskforce: ACS STEMI transfer PCI vs. FL.
Chicago 2014 TFQO: Darren Walters COI #317 EVREV 1: Darren Walters COI #317 EVREV 2: Chris Ghaemmaghami COI #60 Taskforce: Acute Coronary Syndrome In STEMI.
Dallas 2015 TFQO: Anne-Marie Guerguerian # 97 EVREV1: Anne-Marie Guerguerian # 97 EVEREV2: Ericka Fink # 83 Taskforce: PEDS Peds 407 : ECMO for pediatric.
Dallas 2015 TFQO: Darren Walters EVREVs: EVREV 1: Darren Walters COI #422 EVREV 2: Chris Ghaemmaghami COI #89 Taskforce: Acute Coronary Syndrome Fibrinolytic.
First Aid 801: Stroke Recognition
Dallas 2015 TFQO: Name and #COI EVREV 1: Name and #COI Taskforce: Name Insert Short PICO title (including unique PICO ID#) Total of 4 (maximum) using standard.
Dallas 2015 TFQO: David Boyle COI #26 EVREV 1: David Boyle #COI#26 EVREV 1: Jane McGowan #370 Taskforce: Neonatal Ventilation Strategies in the DR (NRP.
Dallas 2015 TFQO: Name and #COI EVREV 1: Name and #COI Taskforce: Name Insert Short PICO title (including unique PICO ID#) Total of 6 (maximum) using standard.
WHO GUIDANCE FOR THE DEVELOPMENT OF EVIDENCE-BASED VACCINE RELATED RECOMMENDATIONS August 2011.
Dallas 2015 TFQO: Michael Sayre COI #400 EVREV 1: Mohamud Daya COI #327 EVREV 2: Jan-Thorsten Gräsner COI #230 Taskforce: BLS BLS 363: CPR Prior to Defibrillation.
Chicago 2014 TFQO: Charles Deakin #329 EVREV 1: Asger Granfeldt COI #63 EVREV 2: Bo Lofgren COI #363 Taskforce: ALS ALS 571 : Ventilation strategy post-ROSC.
Dallas 2015 TFQO: Allan de Caen COI #38 EVREV 1: Tia Raymond COI #153; EVREV 2: Jonathan Egan COI #44 Taskforce: Peds The role of invasive vascular monitoring.
UT Southwestern Medical Center at Dallas
Sifting through the evidence Sarah Fradsham. Types of Evidence Primary Literature Observational studies Case Report Case Series Case Control Study Cohort.
Dallas 2015 TFQO: Kee-Chong Ng (#COI = 170) EVREV 1: Gene Ong (#COI = 118) EVREV 2: Jos Bruinenberg (#COI = 19) Taskforce: Pediatric Taskforce The Long.
Dallas 2015 TFQO: Vinay Nadkarni #375 EVREV 1: Vinay Nadkarni #375 EVREV 1: Dave Kloeck #126 Taskforce: Paeds Paed 424: Vasopressors in Paediatric cardiac.
Chicago 2014 Pediatric RRT/MET Teams #397 TFQO: Dianne Atkins COI #7 EVREV 1: Dianne Atkins EVREV 2: Kee Chong Ng COI #113 Taskforce: Peds.
TFQO: Jasmeet Soar #COI 272 EVREV 1: Jasmeet Soar #COI 272 EVREV 2: Michael Donnino #COI 222 Taskforce: ALS ALS 448 OXYGEN DOSE AFTER ROSC IN ADULTS 3.
Dallas 2015 TFQO: Maaret Castrén #320 EVREV 1: Christian Vaillancourt #416 EVREV 2: Michael Sayre #400 Taskforce: BLS BLS 359: Dispatcher Instructions.
Dallas 2015 TFQO: Jan Jensen COI #115 EVREVs: Jan Jensen COI #115 Richard N. Bradley COI #151 Taskforce: First Aid 769: Hemostatic Dressings.
Dallas 2015 TFQO: Monica Kleinman COI #353 EVREV 1: Janice Tijssen COI#232 EVREV 2: Javier Urbano COI#240 Taskforce: Peds Peds 815: Pediatric goal-directed.
Dallas 2015 TFQO: Judith Finn EVREVs: Judith Finn #227 / Dion Stub #COI Taskforce: EIT Cardiac Arrest Centres.
Dallas 2015 TFQO: Michael W. Donnino COI# EVREVs: Katherine M. Berg COI# Lars W. Andersen COI# Taskforce: ALS Ultrasound During CPR.
Dallas 2015 TFQO: Jan Jensen COI #115 EVREV: Michael Reilly COI #193 Taskforce: First Aid First Aid 768: Use of Tourniquet.
Dallas 2015 TFQO: Jerry Nolan #310 EVREV 1: Jerry Nolan COI #301 EVREV 2: Jan-Thorsten Graesner COI #150 Taskforce: ALS ALS 783 : Advanced versus basic.
Dallas 2015 TFQO: Robert Greif EVREVs: Dana Edelson, COI #334 Robert Greif, COI #344 Taskforce: EIT EIT 645: Debriefing of resuscitation performance.
Dallas 2015 TFQO: Hiroshi Nonogi #254 EVREVs: Hiroshi Nonogi #254 Tony Scott #138 Taskforce: ACS Fibrinolytic and immediate PCI for STEMI 882.
LINC Trial LUCAS in cardiac arrest trial. What is LINC? A multicenter, randomized, controlled trial designed to evaluate the efficacy and safety of: LUCAS.
Dallas 2015 TFQO: S. Velaphi EVREV 1: N. Singhal COI #213 EVREV 2: S. Velaphi COI #242 EVREV 3: H. Ersdal – COI # 76 Taskforce: NLS Prognosis: In newborn.
Dallas 2015 TFQO: Karen Woolfrey #COI 261 EVREV 1: Karen Woolfrey # COI 261 EVREV 2: Daniel Pichel #COI 513 Taskforce: ACS ACS 872: Pre-hospital Diversion.
Dallas 2015 TFQO: Name EVREVs: Names and #COI Taskforce: Name Insert Short PICO title Total of 12 (no studies) to 20 slides (maximum) using standard format.
Dallas 2015 TFQO: Jonathan Witt (COI #418) EVREVs: Steve Lin (COI #137), Thomas Pellis (COI #186) and Katie Dainty (COI #) Taskforce: ALS ALS 428 : Antiarrhythmic.
Chicago 2014 TFQO: Clifton Callaway # EVREV 1: Janice Zimmerman # EVREV 2: Jonathan Sullivan COI # Taskforce: ALS ALS 790 : Induced Hypothermia.
GRADE Grading of Recommendations Assessment, Development and Evaluation British Association of Dermatologists April 2014.
Clinical Practice Guidelines: Can we fix Babel? Eddy Lang Department Chair, Emergency Alberta Health Services Associate Professor University of Calgary.
2010 년 AHA 심폐소생술 가이드라인 설명회 Chest compression & BLS algorithm 연세대학교 강남세브란스병원 응급의학과 정성필.
Abstract Cardiopulmonary Resuscitation with Rescue Breathing Is Superior to Hands-Only Cardiopulmonary Resuscitation for Children and Infants: Results.
Dallas 2015 TFQO: Jasmeet Soar #COI 409 EVREV 1: Jasmeet Soar #COI 409 EVREV 2: Anthony Lagina #COI 357 Taskforce: ALS ALS 889 OXYGEN DOSE DURING CPR IN.
Dallas 2015 TFQO: Michael Donnino #222 EVREV 1: Joshua Reynolds COI #265 EVREV 2: Katherine Berg COI #10 Taskforce: ALS ALS 790 : Induced Hypothermia.
What is LINC? A multicenter, randomized, controlled trial
Presentation transcript:

Dallas 2015 TFQO: Koen Monsieurs 372 EVREV 1: Koen Monsieurs 372 EVREV 2: Ahamed Idris 349 Taskforce: BLS BLS366 Chest Compression Depth (adults)

Dallas 2015 COI Disclosure (SPECIFIC to this systematic review) EVREV 1 COI 358 Commercial/industry Research grant from the Laerdal Foundation Potential intellectual conflicts Editor Guidelines 2015, ERC EVREV 2 COI 302 Commercial/industry None Potential intellectual conflicts Co-author of one study on depth

Dallas Treatment Recommendation It is reasonable to compress the sternum at least 2 inches/5 cm for all adult cardiac arrest victims. There is insufficient evidence to recommend a specific upper limit for chest compression depth.

Dallas 2015 C2015 PICO Population: Among adults who are in cardiac arrest in any setting Intervention: does a different chest compression depth during CPR Comparison: compared with a chest compression depth of at least 5 cm (2 inches) Outcomes: change Survival with favorable neurological/functional outcome at discharge, 30 days, 60 days, 180 days AND/OR 1 year Survival only at discharge, 30 days, 60 days, 180 days AND/OR 1 year ROSC

Dallas 2015 Inclusion/Exclusion & Articles Found Included: all human, comparative studies (prospective and retrospective). Excluded: unpublished studies and studies only published as abstract paediatric studies, manikin studies, animal studies studies that did not specifically address the PICO question Articles initially identified, 10 included in Evidence Profile tables RCTs: 0 Non-RCTs: 9 Non-RCT addressing injury associated with depth: 1

Dallas Proposed Treatment Recommendation Draft Treatment Recommendation: We recommend a chest compression depth range of 4.5 cm to 5.5 cm during manual CPR in adults with cardiac arrest (strong recommendation based on moderate quality evidence).

Dallas 2015 Risk of Bias in Non-RCTs

Dallas 2015 Evidence Profile Table

Dallas 2015 Footnotes to Evidence Table Favorable neurological outcome: Upgraded for dose – response effect. Vadeboncoeur 2014,182 – downgraded for imprecision. 175 (30%) missing data, but imputed into analysis. Did not provide a comparison of characteristics of patients with missing data vs. those with data. Hostler 2011,1512: very serious indirectness. Primary outcome was comparison of feedback vs. no feedback. Depth was an indirect comparison in terms of outcomes. Survival to hospital discharge: Upgraded for dose – response effect. Vadeboncoeur 2014,182; Hostler 2011,1512 – same as above. Stiell 2012,1192; Stiell 2014,1962 – no serious downgrades. ROSC: Upgraded for dose – response effect. Babbs 2008,306 – serious bias for exposure, indirectness, imprecision (T-ROSC is a surrogate for ROSC) Bohn 2011,257 – serious bias for exposure (post hoc analysis), confounding (analysis not adjusted) Edelson 2006,137 - very serious indirectness (outcome was first shock success, not ROSC) Edelson 2008,1063– serious bias (no adjustment), very serious indirectness (analysis included multiple variables and did not isolate the effect of depth) Hostler 2011,1512 – same as above Kramer-Johansen 2006,283 – serious bias (no comparison of excluded (21%) vs. included patients), depth was post-hoc analysis Stiell 2012,1192; Stiell 2014,1962 – no serious downgrades.

Dallas 2015 Proposed Consensus on Science Statements For the critical outcome “survival with good neurological outcome”, we found very low quality evidence from two observational studies [Vadeboncoeur 2014,182] [Hostler 2011,1512] suggesting that a compression depth in adults of more than 5 cm is better than all other compression depths during manual CPR. Evidence was downgraded for serious bias, imprecision, and indirectness. [Vadeboncoeur 2014,182: Neurological outcome, percent of compressions ≥ 51 mm, adjusted odds ratio 1.21 (CI 1.00 – 1.46) N=593, 175 missing data, which was imputed]

Dallas 2015 Proposed Consensus on Science Statements (Cont.) For the critical outcome “survival to hospital discharge”, we found moderate quality evidence from four observational studies [Vadeboncoeur 2014,182] [Hostler 2011,1512] [Stiell 2012,1192] [Stiell 2014,1962] suggesting that a compression depth range of 4.5 to 5.5 cm in adults is better than all other compression depths during manual CPR. Evidence was upgraded for a dose-response relationship; the two largest studies had no serious bias. [Stiell 2014,1962: Survival, N=9,136, adjusted cubic spline, optimal depth range 40 to 55 mm, peak at 46 mm]

Dallas 2015 Proposed Consensus on Science Statements (cont.) For the critical outcome “ROSC”, we found moderate quality evidence from eight observational studies [Babbs 2008,306] [Bohn 2011,257] [Edelson 2006,137] [Edelson 2008,1063] [Hostler 2011,1512] [Kramer-Johansen 2006,283] [Stiell 2012,1192] [Stiell 2014,1962] suggesting that a compression depth of more than 5 cm (range 4.5 to 5.5 cm) in adults is better than all other compression depths during manual CPR. Evidence was upgraded for a dose - response relationship; the two largest studies had no serious bias. [Stiell 2014,1962: N=9,136, ROSC, depth 38 – 51 mm, adjusted OR 0.86 (CI 0.75 – 0.97), reference ≥51 mm] [Note: this study supports >5 cm for ROSC]

Dallas 2015 For the important outcome “injury”, we found very low quality evidence from one observational study [Hellevuo 2013,760] suggesting that a compression depth of more than 6 cm is associated with an increased rate of injury in adults when compared with compression depths of 5 to 6 cm during manual CPR. Evidence was downgraded for serious risk of bias (confounding), imprecision, and very serious indirectness. N=170 (total 353, 183 excluded for incomplete data). With compression depth >6 cm, 63% had injuries; depth 6 cm were 28%, 27%, and 49% respectively. Proposed Consensus on Science Statements (cont.)

Dallas 2015 Draft Treatment Recommendations Draft Treatment Recommendation: We recommend a chest compression depth range of 4.5 cm to 5.5 cm during manual CPR in adults with cardiac arrest (strong recommendation based on moderate quality evidence). Values and preferences statement In making this recommendation, we placed importance on adequate compression depth. We put an upper limit on compression depth in adults because no additional outcome benefit was demonstrated with compression depths of more than 6 cm and because of the possibility of increased rate of injury. We considered the additional training cost to be minimal. The cost to adjust limits in compression depth feedback devices would be modest.

Dallas 2015